Manuel BARDIES

INSERM

France

Research Interests

Explore related searches

Professors in France Professors in Medical Imaging Medical Imaging professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Bernhard Sattler

Vice Deptatment Chair Natural Sciences / Head Medical Physics and Radiation Protection

GERMANY

View details

Stefan Janaqi

University of Montpellier

FRANCE

View details

Emmanuel Deshayes

University of Montpellier

FRANCE

View details

Kalliopi Platoni

GREECE

View details

George Kagadis

Professor of Medical Physics - Medical Informatics

University of Patras

GREECE

View details

Jens Kurth

Head of Medical Physics

Rostock University Medical Center

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manuel BARDIES

Research Interests

Explore related searches

Contact this professor

Articles (10)

Digital twins in nuclear medicine: A proposition of a modular pipeline for dosimetry protocol optimization in molecular radiotherapy

Methodology for comparing absorbed dose rate calculation algorithms in molecular radiotherapy dosimetry

Implementation of dosimetry for molecular radiotherapy; results from a European survey

Symposium on molecular radiotherapy dosimetry: The first of a series?

Quality Assurance Considerations in Radiopharmaceutical Therapy Dosimetry Using PLANETDose: An International Atomic Energy Agency Study.

EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy – Molecular radiotherapy

Technical note: Impact of dose voxel kernel (DVK) values on dosimetry estimates in <sup>177</sup> Lu and <sup>90</sup> Y radiopharmaceutical therapy (RPT) applications.

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project.

A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH)

Therapeutic efficacy of <sup>166</sup>Holmium siloxane in microbrachytherapy of induced glioblastoma in minipig tumor model.

Collaborators (6)

Bernhard Sattler

Stefan Janaqi

Emmanuel Deshayes

Kalliopi Platoni

George Kagadis

Jens Kurth

Make your next move.